The expression and regulation of EZH2 in human renal tissue

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055136

Enrollment

Unknown

Registered

2022-01-01

Start date

2022-01-01

Completion date

Unknown

Last updated

2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease (CKD)

Interventions

Gold Standard:eGFR<60ml/min/1.73m^2

Index test:EZH2

Eligibility

Sex/Gender

All

Age

18 Years to 98 Years

Inclusion criteria

Inclusion criteria: Chronic kidney disease patients admitted to Shanghai Dongfang Hospital.

Exclusion criteria

Exclusion criteria: Pregnancy, serious infection, combined with other malignant tumors, those who are undergoing other clinical trials.

Design outcomes

Primary

Measure	Time frame
EZH2;	—

Countries

China

Contacts

Public ContactLiu Na

naliubrown@163.com+86 18217768587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026